查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726203

美國精神藥物市場規模、佔有率和趨勢分析報告：按產品、形式、應用、分銷管道和細分市場預測，2025 年至 2030 年

U.S. Nootropics Market Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By Form (Powder, Drinks, Gummies), By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國精神藥物市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，美國精神藥物市場預計到2030年將達到46.8億美元，2025年至2030年期間的複合年成長率為9.0%。

這種強勁的成長主要是由於消費者對認知增強產品的認知和接受度不斷提高。社會越來越關注在苛刻的專業和學術環境中的心理表現，加上日益成長的老齡人口擔心認知能力下降，這些都極大地推動了需求。此外，精神活性藥物的用途已不再僅僅增強認知功能，還包括情緒支持和減輕壓力等領域，這擴大了市場吸引力並吸引了更多樣化的消費者群體。

到 2024 年，天然產品將佔很大比例。這是因為消費者偏好溫和、安全的健康和保健解決方案。這種偏好很大程度上受到「天然」與更少的合成化學物質以及潛在的更輕微的副作用的聯繫的影響。天然精神活性藥物的有效行銷和品牌推廣進一步提升了它們的市場主導地位，利用了更廣泛的「潔淨標示」和植物來源趨勢，這些趨勢引起了注重健康的消費者的強烈共鳴，他們尋求符合自然、整體健康理念的認知增強解決方案。

預計能量飲料將在 2024 年佔據最大的市場佔有率。這是因為能量飲料對消費者來說具有固有的便利性和可用性。即飲精神飲料可以無縫融入日常生活，並且比膠囊或粉末更容易飲用。此外，飲料通常具有快速吸收和快速起效的印象，符合許多精神藥物使用者所期望的即時認知增強效果。這種飲料形式還允許在風味特徵和味道遮罩方面具有更大的靈活性，從而增強偏好並吸引更廣泛的消費者群體。

到 2024 年，認知增強將佔據美國精神藥物產業的最大佔有率。這一成長將解決這些材料的核心和最廣為人知的用途。根本動力在於社會越來越重視在生活的許多領域中（從要求專業到競爭激烈的學術追求）的最佳心理表現。人們正在積極尋求解決方案來提高他們的注意力、記憶力、注意力和學習能力，以獲得競爭優勢並提高生產力。

主要市場參與企業包括利潔時集團 (Schiff RB Health (美國 ) LLC)、聯合利華 Onnit Labs, Inc.、安麗、GNC Holdings, LLC、NeuroGum, Inc.、Qualia Life Sciences, LLC、NOW Foods.、Performance Lab USA Corp.、Natural Stacks、BrainMD Health 和 Nootropic Depot。這些公司正在採取各種措施來增加市場佔有率，包括推出新產品、夥伴關係、併購和全球擴張。

美國精神藥物市場報告重點

  • 按產品分類，預計合成部分在預測期內將以顯著的複合年成長率成長。其有針對性的認知增強能力和精確的配方正在刺激成長。持續的研究和開發使得開發具有特異性作用機制和比天然萃取物更強效力的新型合成化合物成為可能。生產合成化合物可以更好地控制純度和一致性，從而可能產生更可預測和可靠的效果，從而吸引尋求最佳化、自訂認知效果的用戶。
  • 根據形式，由於其有吸引力且方便的形式，預計軟糖在預測期內將以顯著的複合年成長率成長。軟糖易於食用，提供有趣的消費體驗，遮罩成分的潛在苦味，並模仿流行糖果甜點的味道。
  • 根據應用，睡眠最佳化部分預計在預測期內以更快的複合年成長率成長。人們越來越意識到睡眠在認知功能和整體健康中的重要作用，以及睡眠障礙和壓力相關睡眠問題的發生率不斷增加，推動了對天然睡眠輔助劑的需求。
  • 根據分銷管道，由於可訪問性和便利性的提高，預計預測期內線上部分將以更快的複合年成長率成長。與實體店相比，網路商店提供更廣泛的精神活性藥物選擇，並且由於管理費用降低，通常提供有競爭力的價格。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國精神藥物市場變數、趨勢與範圍

  • 市場體系展望
  • 產業價值鏈分析
    • 原料展望
    • 製造業和技術展望
    • 利潤率分析
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會
    • 市場問題
  • 產業分析—波特五力分析
  • 打入市場策略

第4章美國精神藥物市場：產品、估計與趨勢分析

  • 美國精神藥物市場（按產品分類）：關鍵要點
  • 2024 年及 2030 年產品趨勢分析及市場佔有率
  • 按產品，2018-2030
    • 自然的
    • 合成

第5章美國精神藥物市場形式、估計與趨勢分析

  • 美國精神藥物市場（按劑型分類）：關鍵要點
  • 2024年和2030年的形態變化分析和市場佔有率
  • 按格式，2018-2030
    • 膠囊/錠劑
    • 粉末
    • 喝
    • 軟糖
    • 其他（液體、貼片、新型給藥方式）

第6章美國精神藥物市場：按應用的估計和趨勢分析

  • 美國精神藥物市場（按應用）關鍵要點
  • 2024年及2030年應用變化分析及市場佔有率
  • 按應用，2018-2030 年
    • 提升認知能力
    • 情緒和壓力管理
    • 睡眠最佳化
    • 能量和身體表現
    • 其他（微循環、抗衰長壽、改善社交焦慮及自信心、增強創造力）

第7章美國精神藥物市場：按分銷管道分類的估計和趨勢分析

  • 美國精神藥物市場分銷管道分析：關鍵要點
  • 2024年及2030年通路變化分析及市場佔有率
  • 按格式，2018-2030
    • 離線
    • 線上

第8章 競爭分析

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 參與企業概況
  • 2024年公司市場佔有率分析（%）
  • 公司熱圖分析
  • 戰略地圖
  • 公司簡介
    • Qualia Life Sciences, LLC
    • Unilever（Onnit Labs, Inc.）
    • GNC Holdings, LLC
    • Performance Lab USA Corp.
    • NeuroGum, Inc.
    • Natural Stacks
    • Nootropics Depot
    • BrainMD Health
    • Reckitt Benckiser Group PLC（Schiff RB Health（US）LLC）
    • NOW Foods.
Product Code: GVR-4-68040-550-7

U.S. Nootropics Market Growth & Trends:

The U.S. nootropics market size is estimated to reach USD 4.68 billion in 2030, growing at a CAGR of 9.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base.

Natural products held a major share in 2024. This is due to consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of "natural" with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness philosophies.

The drinks segment held the largest share in 2024.This can be attributed to their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate into daily routines, offering an easily consumable format compared to capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format also allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal to a wider consumer base.

Cognitive enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers to competitive academic pursuits. Individuals are actively seeking solutions to improve focus, memory, attention span, and learning capabilities to gain a competitive edge and enhance productivity.

Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others to gain more share of the market.

U.S. Nootropics Market Report Highlights:

  • Based on product, the synthetic segment is estimated to grow at a substantial CAGR over the forecast period. The capacity for targeted cognitive enhancement and precise formulations have stimulated the growth. Ongoing research enables the development of novel synthetic compounds with specific mechanisms of action and enhanced potency compared to natural extracts. Synthetic production allows for greater control over purity and consistency, potentially leading to more predictable and reliable effects, appealing to users seeking optimized and tailored cognitive benefits.
  • Based on form, the gummies segment is anticipated to grow at a significant CAGR over the forecast period, driven by the appealing and convenient format of gummies. Gummies offer a palatable and enjoyable consumption experience, masking the potential bitterness of ingredients and resembling popular confectionery.
  • Based on application, the sleep optimization segment is anticipated to grow at a faster CAGR over the forecast period. The increasing recognition of sleep's crucial role in cognitive function and overall well-being and rising rates of sleep disorders and stress-induced sleep issues are driving demand for natural sleep aids.
  • Based on distribution channel, the online segment is anticipated to grow at a faster CAGR over the forecast period due to enhanced accessibility and convenience. They offer a wider selection of nootropics compared to brick-and-mortar stores, often at competitive prices due to reduced overhead.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Product Outlook
  • 2.3. Form Outlook
  • 2.4. Application Outlook
  • 2.5. Distribution Channel Outlook

Chapter 3. U.S. Nootropics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Raw Material Outlook
    • 3.2.2. Manufacturing & Technology Outlook
    • 3.2.3. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis - Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. U.S. Nootropics Market: Product Estimates & Trend Analysis

  • 4.1. U.S. Nootropics Market, By Product: Key Takeaways
  • 4.2. Product Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
    • 4.3.1. Natural
      • 4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.3.2. Synthetic
      • 4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. Nootropics Market: Form Estimates & Trend Analysis

  • 5.1. U.S. Nootropics Market, By Form: Key Takeaways
  • 5.2. Form Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
    • 5.3.1. Capsules/Tablets
      • 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.2. Powder
      • 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Drinks
      • 5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Gummies
      • 5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.5. Others (Liquid, patches, and novel delivery methods)
      • 5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Nootropics Market: Application Estimates & Trend Analysis

  • 6.1. U.S. Nootropics Market, By Application: Key Takeaways
  • 6.2. Application Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Market Estimates & Forecasts, by Application, 2018 - 2030 (USD Million)
    • 6.3.1. Cognitive Enhance
      • 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Mood & Stress Management
      • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Sleep Optimization
      • 6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Energy & Physical Performance
      • 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting)
      • 6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. U.S. Nootropics Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. U.S. Nootropics Market, By Distribution Channel: Key Takeaways
  • 7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
  • 7.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
    • 7.3.1. Offline
      • 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2. Online
      • 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2024 (%)
  • 8.7. Company Heat Map Analysis
  • 8.8. Strategy Mapping
  • 8.9. Company Profiles
    • 8.9.1. Qualia Life Sciences, LLC
      • 8.9.1.1. Company Overview
      • 8.9.1.2. Financial Performance
      • 8.9.1.3. Product Portfolios
      • 8.9.1.4. Strategic Initiatives
    • 8.9.2. Unilever (Onnit Labs, Inc.)
      • 8.9.2.1. Company Overview
      • 8.9.2.2. Financial Performance
      • 8.9.2.3. Product Portfolios
      • 8.9.2.4. Strategic Initiatives
    • 8.9.3. GNC Holdings, LLC
      • 8.9.3.1. Company Overview
      • 8.9.3.2. Financial Performance
      • 8.9.3.3. Product Portfolios
      • 8.9.3.4. Strategic Initiatives
    • 8.9.4. Performance Lab USA Corp.
      • 8.9.4.1. Company Overview
      • 8.9.4.2. Financial Performance
      • 8.9.4.3. Product Portfolios
      • 8.9.4.4. Strategic Initiatives
    • 8.9.5. NeuroGum, Inc.
      • 8.9.5.1. Company Overview
      • 8.9.5.2. Financial Performance
      • 8.9.5.3. Product Portfolios
      • 8.9.5.4. Strategic Initiatives
    • 8.9.6. Natural Stacks
      • 8.9.6.1. Company Overview
      • 8.9.6.2. Financial Performance
      • 8.9.6.3. Product Portfolios
      • 8.9.6.4. Strategic Initiatives
    • 8.9.7. Nootropics Depot
      • 8.9.7.1. Company Overview
      • 8.9.7.2. Financial Performance
      • 8.9.7.3. Product Portfolios
      • 8.9.7.4. Strategic Initiatives
    • 8.9.8. BrainMD Health
      • 8.9.8.1. Company Overview
      • 8.9.8.2. Financial Performance
      • 8.9.8.3. Product Portfolios
      • 8.9.8.4. Strategic Initiatives
    • 8.9.9. Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC)
      • 8.9.9.1. Company Overview
      • 8.9.9.2. Financial Performance
      • 8.9.9.3. Product Portfolios
      • 8.9.9.4. Strategic Initiatives
    • 8.9.10. NOW Foods.
      • 8.9.10.1. Company Overview
      • 8.9.10.2. Financial Performance
      • 8.9.10.3. Product Portfolios
      • 8.9.10.4. Strategic Initiatives

List of Tables

  • Table 1 U.S. nootropics market - Key market driver analysis
  • Table 2 U.S. nootropics market - Key market restraint analysis
  • Table 3 U.S. nootropics market estimates & forecast, by product (USD Million)
  • Table 4 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 5 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 6 U.S. Nootropics market estimates & forecast, by form (USD Million)
  • Table 7 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 8 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 9 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 10 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 11 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 12 U.S Nootropics market estimates & forecast, by application (USD Million)
  • Table 13 U.S. Cognitive Enhance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 14 U.S. Mood & Stress Management nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 15 U.S. Sleep Optimization nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 16 U.S. Energy & Physical Performance nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 17 U.S. others market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 18 U.S. nootropics market estimates & forecast, by distribution channel (USD Million)
  • Table 19 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Table 20 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. Noottopics market snapshot
  • Fig. 2 U.S. Nootropics market segmentation & scope
  • Fig. 3 U.S. Nootropics market penetration & growth prospect mapping
  • Fig. 4 U.S. Nootropics market value chain analysis
  • Fig. 5 U.S. Nootropics market dynamics
  • Fig. 6 U.S. Nootropics market Porter's Five Forces analysis
  • Fig. 7 U.S. Nootropics market: Product movement analysis, 2024 & 2030 (%)
  • Fig. 8 U.S. Natural nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 9 U.S. Synthetic nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 10 U.S. Nootropics market: Form movement analysis, 2024 & 2030 (%)
  • Fig. 11 U.S. Capsules/Tablets nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 12 U.S. Powder nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 U.S. Drinks nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. Gummies nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Other nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Nootropics market: Application movement analysis, 2024 & 2030 (%)
  • Fig. 17 U.S. Nootropics market estimates and forecast for cognitive enhance, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Nootropics market estimates and forecast for mood & stress management, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Nootropics market estimates and forecast for sleep optimization, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Nootropics market estimates and forecast for energy & physical performance, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. Nootropics market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Nootropics market: Distribution channel movement analysis, 2024 & 2030 (%)
  • Fig. 23 U.S. Online nootropics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Offline nootropics market estimates and forecast, 2018 - 2030 (USD Million)